The year in brief

FIRST QUARTER

SIGNIFICANT EVENTS DURING THE FIRST QUARTER

– The RayStation treatment planning system was sold to more leading cancer clinics, including Legacy Cancer Institute in the uS, the university hospital in Krakow, Poland, Osaka City university hospital and

Kumamoto university hospital in Japan. In addition, Inova Schar

Cancer Institute in the uS and Radiumhospitalet at Oslo university hospital in Norway expanded their existing RayStation installations. – The Parent Company issued a short-term loan of SEK 200 M to the

Vinstandelsstiftelsen Rayfoundation on commercial terms. – The wholly owned subsidiary in Australia commenced operation. – RaySearch breached an EBITDA-based covenant in the company’s

SEK 350 M revolving credit facility agreement with Skandinaviska

Enskilda Banken (publ) (“SEB”). The utilized amount of SEK 50 M was subsequently repaid in April. The company has now satisfied all covenants and the credit facility is available for utilization.

SECOND QUARTER

SIGNIFICANT EVENTS DURING THE SECOND QUARTER

– The RayStation treatment planning system was sold to several leading cancer clinics, including the Atrium health Carolinas Medical Center and the Radiation Center of Greater Nashua in the uS, the Institute de

Cancerologie Jean Godinot in france, the German Oncology Center in

Cyprus, and the higashi Omi City Gamo Medical Center in Japan. – The Centre hospitalier universitaire vaudois (ChuV) purchased the

RayCare oncology information system and the RayIntelligence data analytics system, and also expanded its RayStation installation with functionality for automatic planning and segmentation with machine learning as well as planning for Accuray’s CyberKnife system. – RaySearch signed a sales agent agreement with Canon Medical

Systems uSA, Inc., enabling RaySearch America’s salesforce to promote Canon Medical’s Aquilion Large Bore CT and Celesteion PET/CT products. – A new version of the RayStation treatment planning system (11A) was released, with support for Accuray’s CyberKnife system, multiple prescriptions, use of multiple GPus in photon Monte Carlo dose calculation as well as tighter integration with RayCare and RayCommand. – New version of the RayCare oncology information system (5A) was released, with support for Accuray’s CyberKnife System, radiation therapy prescriptions, new whiteboard that provides an overview of patient treatments, configurable forms and a range of improvements in task management, scheduling and automation. – RayStation 9 was granted regulatory clearance in China – a significant growth market for RaySearch.

THIRD QUARTER

SIGNIFICANT EVENTS DURING THE THIRD QUARTER

– The RayStation treatment planning system was sold to more leading cancer clinics, including National Cancer Centre Singapore (NCCS),

Centro de Tratamiento e Investigación sobre cáncer Luis Carlos

Sarmiento Angulo (CTIC) in Colombia, and Queen Elizabeth hospital (QEh) in hong Kong. In addition, Iridium Network in Belgium expanded its existing RayStation installation. – Iridium Network in Belgium, one of RaySearch’s development partners for RayCare, decided to invest in RayCare as its primary oncology information system. – RayStation was taken into clinical use together with Accuray’s

CyberKnife treatment delivery system at Centre hospitalier universitaire vaudois (ChuV) in Switzerland.

FOURTH QUARTER

SIGNIFICANT EVENTS DURING THE FOURTH QUARTER

– The RayStation treatment planning system was sold to several leading cancer clinics, including Lanzhou Ion Therapy Co, LTD (LANITh) in

China and uAMS Radiation Oncology Center (agreement with Proton

International Arkansas) in the uS. – RayCare was taken into clinical use with Accuray’s Radixact® treatment delivery system at Swiss Medical Network in Switzerland. – RaySearch and IBA expanded their collaboration around proton therapy in the areas of fLASh radiotherapy, proton arc therapy and better methods for tumor motion tracking during radiation therapy. – RaySearch and Mevion Medical Systems expanded their collaboration on the development of treatment planning methods for fLASh radiotherapy with the Mevion S250i Proton Therapy System. – New version of the RayCare oncology information system was released (5B). This version allows clinics to configure and tailor their workflows for radiation therapy. – New version of the RayStation treatment planning system was released (11B), with new features for adaptive workflows, brachytherapy and radiation therapy with ions. – RaySearch relocated its head office to new premises, which had a significant impact on total consolidated assets. – New CfO of RaySearch took office.